Biotricity Net Profit Margin 2015-2023 | BTCY
Biotricity net profit margin from 2015 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Biotricity Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $0.01B | $-0.02B | -133.33% |
| 2023-09-30 | $0.01B | $-0.02B | -163.64% |
| 2023-06-30 | $0.01B | $-0.02B | -190.00% |
| 2023-03-31 | $0.01B | $-0.02B | -222.22% |
| 2022-12-31 | $0.01B | $-0.02B | -262.50% |
| 2022-09-30 | $0.01B | $-0.02B | -287.50% |
| 2022-06-30 | $0.01B | $-0.03B | -362.50% |
| 2022-03-31 | $0.01B | $-0.03B | -375.00% |
| 2021-12-31 | $0.01B | $-0.03B | -428.57% |
| 2021-09-30 | $0.01B | $-0.03B | -450.00% |
| 2021-06-30 | $0.01B | $-0.02B | -380.00% |
| 2021-03-31 | $0.00B | $-0.02B | -533.33% |
| 2020-12-31 | $0.00B | $-0.02B | -750.00% |
| 2020-09-30 | $0.00B | $-0.01B | -1300.00% |
| 2020-06-30 | $0.00B | $-0.01B | inf% |
| 2020-03-31 | $0.00B | $-0.01B | inf% |
| 2019-12-31 | $0.00B | $-0.01B | inf% |
| 2019-09-30 | $0.00B | $-0.01B | inf% |
| 2019-06-30 | $0.00B | $-0.01B | inf% |
| 2019-03-31 | $0.00B | $-0.01B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.013B | $0.010B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
| Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
| 10x Genomics (TXG) | United States | $3.489B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
| Axonics (AXNX) | United States | $3.396B | 0.00 |
| Enovis (ENOV) | United States | $3.029B | 23.01 |
| Azenta (AZTA) | United States | $2.925B | 238.46 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
| Privia Health (PRVA) | United States | $2.183B | 96.84 |
| Schrodinger (SDGR) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.231B | 30.12 |
| Phreesia (PHR) | United States | $1.169B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
| Pulmonx (LUNG) | United States | $0.293B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| Outset Medical (OM) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.116B | 4.94 |
| 111 (YI) | China | $0.087B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |